Online Survey Successful in Gathering COVID-19 Data at Scale

A pilot project using an online survey to gather data on COVID-19 symptoms received more than 87,000 responses from around the world, providing important insight into the spread of disease. Project leaders from Regenstrief Institute, Indiana University and Microsoft believe these questionnaires could be a valuable tool for population health.

The 7-question survey was launched in multiple languages during April 2020, as lockdowns were implemented to slow the spread of COVID-19. A link to the survey was placed in banner ads in Microsoft News articles. Respondents answered questions about experiencing COVID-19 symptoms, testing and their recent travel. The survey was voluntary and anonymous.

The survey captured 87,322 respondents during a three-week period. Responses included people from every U.S. state and nearly every county in each state. 85.2 percent of the respondents were from the U.S. and Japan, and more than half of those were 50 years or older.

"We found this survey method to be feasible for collecting large-scale data from people in the community, enhancing disease surveillance," said study author Brian Dixon, PhD, MPA, director of public health informatics at Regenstrief Institute and IU Richard M. Fairbanks School of Public Health at IUPUI. "The population in this survey skewed older and reflects individuals who participate in traditional opinion surveys. Volunteers come across our call for help while, simply, reading the news. Other social media sites trend younger and draw from individuals constantly bombarded with quizzes and marketing surveys. Furthermore, the news platform we used was able to reach the population who is at higher risk of complications from COVID-19, which is important to monitor and target in public health efforts during this pandemic."

The data gathered is unique because it comes from community residents rather than people who were hospitalized with the disease. The survey revealed several interesting insights about patterns of symptoms.

  • Those who reported loss of taste or smell and fever, symptoms associated with active SARS-CoV-2 infection, were more likely to have been tested for COVID-19.
  • Individuals reporting symptoms were more likely to report travelling more than 15 miles from their home within the past two weeks.
  • Those without symptoms were significantly less likely to report being tested. However, testing infrastructure in the U.S. was limited at the time of the survey.
  • The number of people reporting symptoms was correlated with the testing rates in U.S. states, indicating that symptom monitoring could be a proxy for testing in places where testing might be limited.

"This approach offers access to a wide audience, many of whom might not be captured in other data gathering methods," said study author Mary L. Gray, PhD, senior principal researcher at Microsoft Research and faculty at Indiana University Luddy School of Informatics, Computing, and Engineering. "This work sheds light on the potential uses of this method for the current pandemic and other circumstances where data gathering at scale is needed quickly."

"Based on our results, online news tools can be a useful strategy for reaching broad and diverse populations during emerging outbreaks. It is a quick and easy way to gather a significant amount of data and appears to accurately capture what is happening in the community at large," said study author Shaun Grannis, M.D., M.S., Regenstrief vice president for data and analytics and IU School of Medicine professor of family medicine. "Combined with other methods, online news tools can help public health organizations quickly assess trends in emerging infections before individuals seek treatment, allowing a faster public health response."

The research team launched a second online survey in December 2020 to expand efforts to track symptoms, understand population behavior, and gather insights on vaccine attitudes.

Dixon BE, Mukherjee S, Wiensch A, Gray ML, Ferres JML, Grannis SJ.
Capturing COVID-19 - Like Symptoms at Scale Using Banner Ads on an Online News Platform: Pilot Survey Study.
J Med Internet Res 2021;23(5):e24742. doi: 10.2196/24742

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...